Search for: "Kurt R. Karst" Results 201 - 220 of 351
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
The FTC’s Latest Patent Settlement Report Will Serve as Fodder for the Commission’s Crusade Against Patent Settlement Agreements
8 May 2011, 8:13 am by FDABlog HPM
By Kurt R. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
D.C. Circuit is Asked to Review Two DESI “New Drug” Decisions
2 May 2011, 5:45 pm by FDABlog HPM
By Kurt R. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Academics Criticize the MMA’s Failure-to-Market Forfeiture Provisions as an Anemic Mechanism for Parked Exclusivity and the MMA’s DJ Provisions as a Paper Tiger
27 Apr 2011, 9:03 am by FDABlog HPM
By Kurt R. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Analyst Report Suggests Recent Uptick in NDA/BLA Refuse-to-File Letters Signals Changes at FDA
26 Apr 2011, 1:56 pm by FDABlog HPM
By Kurt R. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Amendment to the America Invents Act Would Give MDCO Some Legislative Security in Battle Over ANGIOMAX PTE
20 Apr 2011, 5:21 pm by FDABlog HPM
By Kurt R. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
ViroPharma’s Preemptive Strike Over Generic VANCOCIN Fails; District Court Grants FDA’s Motion to Dismiss
19 Apr 2011, 8:23 am by FDABlog HPM
By Kurt R. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
New IP resource for Pharma, Biotech and Chem – Tie-in / tie-out clauses and competition
18 Apr 2011, 10:12 pm by Marie Louise
Jenkins, UK Fabrizio Jacobacci, Studio Legale Jacobacci & Associati, Italy Kurt R. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Lawsuit Alleges False Marking Based on Orange Book “Advertising”
13 Apr 2011, 5:13 pm by FDABlog HPM
By Kurt R. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
FDA Reports to Congress on Generic Anti-Epileptic Drugs; Concludes that Additional Study of Brand-Generic Switching is Needed to Better Understand Risks
13 Apr 2011, 10:10 am by FDABlog HPM
By Kurt R. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Simultaneously Qualifying for and Forfeiting 180-Day Exclusivity Eligibility for Failure to Obtain Timely Tentative Approval
12 Apr 2011, 2:47 pm by FDABlog HPM
By Kurt R. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
NJ District Court Punts in ASACOL DJ Action to Trigger 180-Day Exclusivity Forfeiture; Rules that Subsequent ANDA Applicant Lacks Standing
5 Apr 2011, 2:35 pm by FDABlog HPM
By Kurt R. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Decision in Lannett THALOMID Bioequivalence Study Sample Antitrust Lawsuit Could Reignite Debate on Generic Drug Availability and REMS Restrictions
3 Apr 2011, 10:21 pm by FDABlog HPM
By Kurt R. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Oral Argument in the Mensing-Demahy Generic Drug Labeling Preemption Case
30 Mar 2011, 5:32 pm by FDABlog HPM
By Kurt R. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Orange Book Patent Listing Precipitates DJ Action to Trigger Generic KEPPRA XR 180-Day Exclusivity Forfeiture
28 Mar 2011, 2:42 pm by FDABlog HPM
By Kurt R. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Pharmaceutical, Biotechnology and Chemical Inventions - World Protection and Exploitation
24 Mar 2011, 10:12 am by FDABlog HPM
Dormer and Kurt R. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
New IP resource for Pharma, Biotech and Chem – Compulsory licences, comparing national requirements
21 Mar 2011, 9:14 pm by Duncan
Jenkins, UK Fabrizio Jacobacci, Studio Legale Jacobacci & Associati, Italy Kurt R. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Sen. Casey Takes Over the Reins for the Creating Hope Act; New Bill Substantially Mirrors Sen. Brownback’s 2010 Version
21 Mar 2011, 1:12 pm by FDABlog HPM
By Kurt R. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
FDA Issues New Guidance on PDUFA User Fee Waivers, Reductions, and Refunds; Guidance Represents the Culmination of 18 Years of FDA Experience
21 Mar 2011, 12:00 pm by FDABlog HPM
Butler & Kurt R. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Judge Snuffs Out Holistic Candlers Lawsuit; Constitutional Challenge Falls on Deaf Ears
20 Mar 2011, 10:10 pm by FDABlog HPM
By Kurt R. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Recent Hatch-Waxman Scholarship Suggests Patent Settlement and Product Hopping Create a “Lethal Combination”; Another Article Proposes a “Smith Barney Approach” to 180-Day Exclusivity
15 Mar 2011, 12:46 pm by FDABlog HPM
By Kurt R. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/